Skip to content

Taghealthcare

a study from researchers at UC San Diego develops a treatment containing healthy vaginal bacteria, in effect a ‘live biotherapeutic’, that successfully treated BV and stopped it from recurring in the 3-month ‘danger window’ after recovery. The team states their new, more natural approach, strengthens the vaginal microbiome against infections, proffering a breakthrough in the long-term prevention of BV.
Posted healthinnovations

Microbiome therapy protects against recurrent bacterial vaginosis.

Bacterial vaginosis (BV) is a commonly occurring bacterial infection affecting approximately thirty percent of women of reproductive age in the United States. BV is linked to the spread of HIV … Continue Reading Microbiome therapy protects against recurrent bacterial vaginosis.